Evidence map›Paper›PMID 37728425›Full record

ArticleJournal of clinical and experimental neuropsychology2023

Recognition subtests of the Repeatable Battery for the Assessment of Neuropsychological Status: evidence for a cortical vs. subcortical distinction.

Julia V Vehar, Shervin Rahimpour, Paolo Moretti, Panagiotis Kassavetis, Jumana Alshaikh, John Rolston, Kevin Duff

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical and experimental neuropsychology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Recognition Subtests for Form B of the Repeatable Battery for the Assessment of Neuropsychological Status: Preliminary Validation.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2025
    Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Julia V VeharDepartment of Psychology, University of Utah, Salt Lake City, Utah, USA.ORCID 0000-0001-9302-640X
Shervin RahimpourDepartment of Neurosurgery, University of Utah, Salt Lake City, Utah, USA.
Paolo MorettiDepartment of Neurology, University of Utah, Salt Lake City, Utah, USA.
Panagiotis KassavetisDepartment of Neurology, University of Utah, Salt Lake City, Utah, USA.
Jumana AlshaikhDepartment of Neurology, University of Utah, Salt Lake City, Utah, USA.
John RolstonDepartment of Neurosurgery, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Kevin DuffDepartment of Neurology, University of Utah, Salt Lake City, Utah, USA.ORCID 0000-0002-9336-2400
University of Utah · USBrigham and Women's Hospital · USOregon Health & Science University · US

Funding

Enriching clinical trials requiring amyloid positivity with practice effectsR01AG055428 · NIA · UNIVERSITY OF UTAH · PI DUFF, KEVIN M, HOFFMAN, JOHN M · 2017 to 2021
$3.6M
NIA NIH HHS R01 AG055428
6 · The paper itself

Abstract

introductionWithin clinical neuropsychology, a classic diagnostic distinction is made between cortical and subcortical disorders, especially based on their memory profiles. Typically, this is based on the comparison of recall and recognition trials, where individuals with cortical conditions do not tend to benefit (i.e., score well) on recognition trials and individuals with subcortical conditions do. Although the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) is a widely used brief cognitive battery, there is a lack of evidence to support this measure's utility in distinguishing between the memory profiles of these conditions.

methodThirty-six mild Alzheimer's disease (AD), 55 Parkinson's disease (PD), and 105 essential tremor (ET) participants (

resultsAs expected, individuals with AD had poorer recognition scores compared to the other clinical groups across tasks (all p-values < .05), while the ET sample largely performed comparably to the PD sample. With the exception of comparable Figure Recognition and Recall in the PD sample, all groups exhibited significantly greater recognition Hit performance compared to Recall (all p-values < .05).

conclusionsThe group differences in performance across RBANS recognition subtests suggest support for traditional "cortical" and "subcortical" profiles. However, all groups, including the mild AD sample, demonstrated a benefit from recognition cues compared to free recall. Overall, these findings support the inclusion of the newly developed Story and Figure Recognition subtests in future clinical practice and research endeavors.

Indexed as

Alzheimer DiseaseParkinson DiseaseCuesHumansMental RecallRecognition, PsychologyAlzheimer’s diseaseEssential tremorParkinson’s diseaseRBANSrecognition

Identifiers

PMID37728425
PMCPMC10922284
OpenAlexW4386878765

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.